Filing Details

Accession Number:
0001398344-23-003358
Form Type:
13G Filing
Publication Date:
2023-02-13 19:00:00
Filed By:
Sessa Capital (master), L.p.
Company:
Provention Bio Inc.
Filing Date:
2023-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Sessa Capital (Master) 6. 18,066,613 8. 18,066,613 18,066,613 19.99%
Sessa Capital GP 18,066,613 7. 18,066,613 9. 18,066,613 19.99%
Sessa Capital IM 18,066,613 7. 18,066,613 9. 18,066,613 19.99%
Sessa Capital IM GP 18,066,613 7. 18,066,613 9. 18,066,613 19.99%
John Petry 18,066,613 7. 18,066,613 9. 18,066,613 19.99%
Filing

 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

SCHEDULE 13G 

 

Under the Securities Exchange Act of 1934

 

(AMENDMENT NO. 2) *

 

PROVENTION BIO, INC.

 

(Name of Issuer)

 

Common Stock, par value $0.0001 per share

 

(Title of Class of Securities) 

 

74374N102

 

(CUSIP Number)

 

December 31, 2022

 

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

[  ]Rule 13d-1(b)
[x]Rule 13d-1(c)
[  ]Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

CUSIP No. 74374N102   13G   Page 1 of 8 Pages

 

1.

NAMES OF REPORTING PERSONS

 

Sessa Capital (Master), L.P.

 
2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

 

(a) [  ]

(b) [  ]

 

3.

SEC USE ONLY

 

 
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Cayman Islands

 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5.

SOLE VOTING POWER

 

6.

SHARED VOTING POWER

 

18,066,613

7.

SOLE DISPOSITIVE POWER

 

8.

SHARED DISPOSITIVE POWER

 

18,066,613

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

18,066,613

 
10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(see instructions) [  ]

 

 
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

19.99%

 
12.

TYPE OF REPORTING PERSON (see instructions)

 

PN

 

 

CUSIP No. 74374N102   13G   Page 2 of 8 Pages

 

1.

NAMES OF REPORTING PERSONS

 

Sessa Capital GP, LLC

 
2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

 

(a) [  ]

(b) [  ]

 

3.

SEC USE ONLY

 

 
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5.

SOLE VOTING POWER

 

18,066,613

6.

SHARED VOTING POWER

 

7.

SOLE DISPOSITIVE POWER

 

18,066,613

8.

SHARED DISPOSITIVE POWER

 

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

18,066,613

 
10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(see instructions) [  ]

 

 
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

19.99%

 
12.

TYPE OF REPORTING PERSON (see instructions)

 

OO

 

 

CUSIP No. 74374N102   13G   Page 3 of 8 Pages

 

1.

NAMES OF REPORTING PERSONS

 

Sessa Capital IM, L.P.

 
2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

 

(a) [  ]

(b) [  ]

 

3.

SEC USE ONLY

 

 
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY

EACH
REPORTING
PERSON WITH

5.

SOLE VOTING POWER

 

18,066,613

6.

SHARED VOTING POWER

 

7.

SOLE DISPOSITIVE POWER

 

18,066,613

8.

SHARED DISPOSITIVE POWER

 

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

18,066,613

 
10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(see instructions) [  ]

 

 
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

19.99%

 
12.

TYPE OF REPORTING PERSON (see instructions)

 

PN

 

 

CUSIP No. 74374N102   13G   Page 4 of 8 Pages

 

1.

NAMES OF REPORTING PERSONS

 

Sessa Capital IM GP, LLC

 
2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

 

(a) [  ]

(b) [  ]

 

3.

SEC USE ONLY

 

 
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5.

SOLE VOTING POWER

 

18,066,613

6.

SHARED VOTING POWER

 

7.

SOLE DISPOSITIVE POWER

 

18,066,613

8.

SHARED DISPOSITIVE POWER

 

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

18,066,613

 
10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(see instructions) [  ]

 

 
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

19.99%

 
12.

TYPE OF REPORTING PERSON (see instructions)

 

OO

 

 

CUSIP No. 74374N102   13G   Page 5 of 8 Pages

 

1.

NAMES OF REPORTING PERSONS

 

John Petry

 
2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a) [  ]

(b) [  ]

 

3.

SEC USE ONLY

 

 
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America

 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5.

SOLE VOTING POWER

 

18,066,613

6.

SHARED VOTING POWER

 

7.

SOLE DISPOSITIVE POWER

 

18,066,613

8.

SHARED DISPOSITIVE POWER

 

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

18,066,613

 
10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(see instructions) [  ]

 

 
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

19.99%

 
12.

TYPE OF REPORTING PERSON (see instructions)

 

IN

 

 

CUSIP No. 74374N102   13G   Page 6 of 8 Pages

 

Item 1. (a)

Name of Issuer

Provention Bio, Inc. (the “Issuer”)

     
  (b)

Address of Issuer’s Principal Executive Offices

55 Broad Street, 2nd Floor

Red Bank, New Jersey 07701

 

Item 2. (a)

Name of Person Filing

 

The names of the persons filing this report (collectively, the “Reporting Persons”) are: 

 

1.      Sessa Capital (Master), L.P.

2.      Sessa Capital GP, LLC 

3.      Sessa Capital IM, L.P.

4.      Sessa Capital IM GP, LLC 

5.      John Petry

     
  (b)

Address of the Principal Office or, if none, residence

 

The address of the principal business office of each of the Reporting Persons is:

 

888 Seventh Avenue, 30th Floor

New York, NY, 10019

     
  (c)

Citizenship

 

Sessa Capital (Master), L.P. – a Cayman Islands exempted limited partnership

Sessa Capital GP, LLC – a Delaware limited liability company

Sessa Capital IM, L.P. – a Delaware limited liability partnership

Sessa Capital IM GP, LLC – a Delaware limited liability company

John Petry – a United States citizen

     
  (d)

Title of Class of Securities

Common Stock, par value $0.0001 per share (“Common Stock”)

     
  (e)

CUSIP Number

74374N102

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

Not applicable.

 

CUSIP No. 74374N102   13G   Page 7 of 8 Pages

 

Item 4. Ownership.

 

The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Schedule 13G/A. The ownership percentages reported are based on the 87,190,667 shares of Common Stock outstanding as of October 31, 2022, as reported in the Issuer’s Form 10-Q filed on November 3, 2022.

 

Sessa Capital (Master), L.P (the “Fund”) directly beneficially owns 14,879,023 shares of Common Stock and 8,879,023 Warrants exercisable on a one-for-one basis for shares of Common Stock pursuant to the Beneficial Ownership Blocker (the “Warrants”), 3,187,590 of which are immediately exercisable under the restrictions contained in the Beneficial Ownership Blocker. The Warrants contain a provision (the “Beneficial Ownership Blocker”) which precludes exercise of the warrants to the extent that, following exercise, the Reporting Person, together with its affiliates and other attribution parties, would beneficially own more than 19.99% of the Common Stock outstanding.

 

Sessa Capital GP, LLC is the general partner of the Fund and, as a result, may be deemed to beneficially own Common Stock owned by the Fund. Sessa Capital IM, L.P. is the investment manager of the Fund and, as a result, may be deemed to beneficially own Common Stock owned by the Fund. Sessa Capital IM GP, LLC is the general partner of Sessa Capital IM, L.P. and, as a result, may be deemed to beneficially own Common Stock beneficially owned by Sessa Capital IM, L.P. John Petry is the manager of Sessa Capital GP, LLC and Sessa Capital IM GP, LLC and, as a result, may be deemed to beneficially own Common Stock owned by the Fund.

 

Item 5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ].

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. 

 

Not applicable

 

Item 8. Identification and Classification of Members of the Group.

 

Not applicable

 

Item 9. Notice of Dissolution of Group.

 

Not applicable

 

CUSIP No. 74374N102   13G   Page 8 of 8 Pages

 

Item 10. Certification.

 

The Reporting Persons hereby make the following certifications:

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

Signature

 

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

       
  By: /s/ John Petry  
    John Petry  
    John Petry, individually, as manager of Sessa Capital GP, LLC, the general partner of Sessa Capital (Master), L.P., and as manager of Sessa Capital IM GP, LLC, the general partner of Sessa Capital IM, L.P.  
       
  Date: February 14, 2023